ABSTRACT
Pulmonary arterial hypertension (PAH) is a rare, but devastating and life-threatening disease, with a profoundly poor prognosis and high mortality. <EM>Pulmonary Arterial Hypertension</EM> enhances the overall 'PAH awareness' of the wider clinical community and outlines the need for screening, effective diagnosis and beneficial treatment.
